We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
A Look at the Numbers: Cost of Durable Treatments in Retinal Disease
Jayanth Sridhar, MD
Sabin Dang, MD
Reconsidering the Algorithm: Treatment-Resistant DME
Durga Borkar, MD, MMCi
Christina Y. Weng, MD, MBA, FASRS
Clinical Evidence for Durable Treatment of nAMD
Clinical Evidence for Durable Treatment of DME
Lessening Glaucoma Treatment Burden: Sustained-Release Therapies (Part 2)
Davinder S. Grover, MD, MPH
Advances in Glaucoma Treatment: MIGS (Part 1)
Emerging Viewpoints on Diabetic Eye Health Disparities
Charles P. Vega, MD
Pradeep S. Prasad, MD, MBA
Ruth Shoge, OD, MPH, FAAO
Sharon D. Solomon, MD
Lessening Glaucoma Treatment Burden with Topical Therapies: The Evidence (Part 2)
Qi Cui, MD, PhD
Lessening Glaucoma Treatment Burden: Sustained-Release Therapies (Part 1)
Advances in Glaucoma Treatment: Individualizing Therapy to Improve Adherence
Lessening Glaucoma Treatment Burden: Clinical Cases (Part 1)
Lessening Glaucoma Treatment Burden with Topical Therapies: The Evidence (Part 1)
Lessening Glaucoma Treatment Burden: Clinical Cases (Part 2)
Advances in Glaucoma Treatment: Novel Topical Therapies
Advances in Glaucoma Treatment: MIGS (Part 2)
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education